Skip to content

Basket

You currently have no items in your basket.

Total (excl. vat) £0.00
View basket & checkout
Proteins and Peptides

Amyloid Beta 1-42 Pre-formed Fibrils

Product Sizes
100 ug
SPR-487-100UG
2 x 100 ug
SPR-487-2X100UG
5 x 100 ug
SPR-487-5X100UG
About this Product
SKU:
SPR-487
Additional Names:
AB Beta 1-42, Amyloid beta, Beta amyloid peptide, Abeta, Abeta peptide, Amyloid beta precursor peptide, APP, Beta-APP42, Abeta42, A4, ABPP, APPI, Alzheimer disease amyloid A4, Alzheimer disease amyloid, Cerebral vascular amyloid peptide, PreA4, Protease nexin-II, PN-II, Amyloid Beta PFFs
Application:
Cell-based/Functional Assay, Western Blot
Buffer:
10 mM HCl + 2% DMSO
CE/IVD:
RUO
Concentration:
1 mg/ml
Extra Details:
Amyloid beta (AB Beta) peptides, particularly the 42-residue variant AB Beta 1-42, are central to the pathology of Alzheimer's disease. Derived from the cleavage of amyloid precursor protein (APP), AB Beta 1-42 is highly prone to misfolding and aggregation. Among its aggregated forms, pre-formed fibrils (PFFs) replicate the B Beta-sheet-rich structures found in amyloid plaques and cerebrovascular deposits in affected brains. [www.uniprot.org] AB Beta 1-42 PFFs are widely used in neurodegenerative disease research to model the progression of amyloid pathology. These fibrils exhibit high structural stability and neurotoxicity, making them ideal for studying mechanisms of synaptic dysfunction, oxidative stress, and neuroinflammation. Their ability to seed endogenous AB Beta aggregation and propagate pathology across brain regions mirrors the prion-like behavior observed in Alzheimer's disease. In experimental systems, AB Beta 1-42 PFFs enable high-resolution analysis of aggregation kinetics, cellular uptake, and downstream signaling disruptions. They are also instrumental in evaluating therapeutic strategies aimed at inhibiting fibril formation, enhancing clearance, and blocking intercellular transmission. By providing a reproducible and disease-relevant platform, AB Beta 1-42 pre-formed fibrils accelerate biomarker discovery and the development of targeted interventions, positioning them as a cornerstone in translational Alzheimer's research. StressMarq's Amyloid Beta 1-42 (AB Beta42) Pre-formed Fibrils are generated from Amyloid Beta Peptide 1-42 pre-treated with 1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP) using a previously published method (1,2). StressMarq's AB Beta42 fibrils present as long strands when observed under TEM and AFM, and have a unique high molecular weight signal on a Western Blot with an anti-amyloid beta antibody. Sonicated AB Beta42 fibrils showed dose-dependently toxic to primary rat cortical neurons.
Immunogen:
Amyloid Beta PFFs
Molecular Weight:
4.5 kDa
Purity:
>95%
Sequence:
MDVFMKGLSK AKEGVVAAAE KTKQGVAEAA GKTKEGVLYV GSKTKEGVVH GVATVAEKTK EQVTNVGGAV VTGVTAVAQK TVEGAGSIAA ATGFVKKDQL GKNEEGAPQE GILEDMPVDP DNEAYEMPSE EGYQDYEPEA
Shipping Conditions:
Dry Ice
Storage Conditions:
-70[o]C
Supplier:
StressMarq Biosciences
Type:
Proteins, Peptides, Small Molecules & Other Biomolecules: Synthetic
TEM of amyloid beta 1-42 monomers (SPR-485, left), oligomers (SPR-488, middle) and fibrils (SPR-487, right). Negative stain transmission electron microscopy images acquired at 80 Kv on carbon coated 400 mesh copper grids using phosphotungstic acid and uranyl acetate stain. Scale bar = 100 nm.
Western blot of amyloid beta 1-42 monomers (SPR-485, left), oligomers (SPR-488, middle) and fibrils (SPR-487, right) using anti-amyloid beta 6E10 antibody. Amyloid beta constructs at 160 pmol were run on 4-12% Bis-Tris SDS-PAGE, transferred to nitrocellulose in the presence of 0.02% v/v Tween-20, and blotted with 1:1000 mouse 6E10 primary antibody (Biolegend). Oligomers observed under TEM/AFM appear as distinct dimer/trimer bands at ~37-75 kDa on Western Blot with 6E10 antibody (middle). Fibrils observed under TEM/AFM appear as a distinct signal at greater than 100 kDa in the stacking gel (right).
Amyloid beta 1-42 oligomers (SPR-488) and fibrils (SPR-487) show a dose-dependent toxicity to primary rat cortical neurons, but not monomers (SPR-485). Survival of rat primary cortical neurons 14 days after treatment with different concentrations of (A) monomers, (B) oligomers or (C) fibrils quantified by MAP2 positive neurons and expressed as a percentage of control. Fibrils and respective vehicle controls were initially sonicated in a Bioruptor. Test conditions were run in the same plate as untreated control and vehicle controls, which consisted of buffer without amyloid beta 1-42 protein. Data expressed as mean +/- s.e.m. (n=6). A global analysis of the data was performed using a one-way ANOVA followed by Dunnett's test; ** p<0.01 stats vs control; ## p<0.01, #### p<0.0001 stats vs vehicle control. represents untreated control condition.
Human iPSC-derived microglia uptake of StressMarq Amyloid Beta 1-42 Pre-formed Fibrils (SPR-487) conjugated to Phrodo dye. Live cell imaging performed by reMYND (Leuven, Belgium) using Ex560 Em585.
AFM of amyloid beta 1-42 monomers (SPR-485, left), oligomers (SPR-488, middle) and fibrils (SPR-487, right). Atomic force microscopy analysis of 1.0 mg/mL samples diluted to 0.1 mg/mL in dH2O, mounted on freshly cleaved mica, washed, dried and analyzed with tapping mode. Representative images are 2.5 x 2.5 um x-y with a z-range of 10 nm.